Artículos del autor

solaci

Scientific Articles COVID-19

Efficacy of the Sinopharm Vaccine Against COVID-19

Vaccines developed with two different inactivated strains of SARS-CoV-2 (Sinopharm) significantly reduced the risk of symptomatic cases...
solaci -
Institutional News

16/06 | SOLACI Masterclass: Coronary Access After TAVR

solaci -
Femoropopliteal

ELUVIA: DES in Complex Femoropopliteal Lesions

Paclitaxel-eluting stent Eluvia showed promising results after two years with a revascularization freedom rate of 80% despite...
solaci -
Scientific Articles COVID-19

COVID-19 Risk in Vaccinated Healthcare Workers

Vaccinated healthcare workers have a risk of being infected with SARS-CoV-2 of about 1%, a rate that...
solaci -
Institutional News

Watch again our Webinar on Pressure Gradients After TAVR: Paradigm Shift?

Watch again our Webinar on "Pressure Gradients After TAVR: Paradigm Shift?" on our Youtube account. The event...
solaci -
Institutional News

Official Presentation of SOLACI / SIAC Latin American Clinical TAVR Guidelines

The Latin American Society of Interventional Cardiology (SOLACI) and the Inter-American Society of Cardiology (SIAC) have jointly...
solaci -
Antiplatelet

DAPT vs. Monotherapy: The Dilemma Remains After Surgery

Patients who undergo myocardial revascularization surgery and are discharged on dual antiplatelet therapy (DAPT)—aspirin plus clopidogrel—have a...
solaci -
Scientific Articles COVID-19

Primary COVID-19 Infection Protects Against Potential Reinfection?

These study outcomes suggest reinfection is relatively rare in patients who recover from COVID-19. In addition, natural...
solaci -